Pharmagreen Biotech Inc. Quarterly Return On Equity in % from Q3 2019 to Q4 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Pharmagreen Biotech Inc. quarterly/annual Return On Equity history and growth rate from Q3 2019 to Q4 2022.
  • Pharmagreen Biotech Inc. Return On Equity for the quarter ending December 31, 2022 was 46.9 %, a 80% decline year-over-year.
  • Pharmagreen Biotech Inc. annual Return On Equity for 2022 was 45.2 %, a 82.2% decline from 2021.
  • Pharmagreen Biotech Inc. annual Return On Equity for 2021 was 253 %, a 84.4% increase from 2020.
  • Pharmagreen Biotech Inc. annual Return On Equity for 2020 was 137 %, a 61.7% increase from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2022 46.9 -188 -80% Oct 1, 2022 Dec 31, 2022
Q3 2022 45.2 -208 -82.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 83.8 -136 -61.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 106 -159 -60.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 234 +98.6 +72.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 253 +116 +84.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 220 +79.8 +57% Apr 1, 2021 Jun 30, 2021
Q1 2021 265 +211 +388% Jan 1, 2021 Mar 31, 2021
Q4 2020 136 +71.6 +111% Oct 1, 2020 Dec 31, 2020
Q3 2020 137 +52.4 +61.7% Jul 1, 2020 Sep 30, 2020
Q2 2020 140 Apr 1, 2020 Jun 30, 2020
Q1 2020 54.4 Jan 1, 2020 Mar 31, 2020
Q4 2019 64.3 Oct 1, 2019 Dec 31, 2019
Q3 2019 84.9 Jul 1, 2019 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.